Twisted Tale: MD Charged In Medicaid Drug Fraud Scheme Once Helped Drug Users
That year, in a story about HIV users, the New York Times sought her out to talk about her involvement with AIDS patients, and the problems of drug abuse. Then medical director of Harlem United, a nonprofit advocacy group for people with AIDS, as well as a clinical research fellow at Mount Sinai Medical Center in Manhattan, she told The Times of what she knew on the streets, saying "it's a world unto itself and (people) don't get respected the way they should."
When she was profiled by Crains, Williamson discussed respect, in terms of those abusing drugs. "My thing is, don't look down on the drug users; don't judge them," Williamson said. "They deserve care."
Respect and care, it's all true what she says about people battling drug issues. But with what authorities allege now, the woman who was among the "40 under 40" rising stars to watch in New York faces the prospect of 20 years in prison if convicted of the charges against her.
She and other defendants are charged with one count of conspiracy to distribute and possess a controlled substance, with also carries a maximum penalty of $1 million. Williamson and another co-defendant are also charged with one count of conspiracy to commit healthcare fraud, which carries another multi-year prison term.
Williamson's attorney, John Marks, could not be reached. Officials of the Citicare Inc., a medical clinic where she recently worked, declined to discuss her case.
The contrast between the Crain's article and the U.S. Attorney's complaint from the Southern District of Manhattan could not be starker.
- Reform Puts Vise Grips on Physicians
- Medicare Opt-Out a Viable Physician Strategy
- Look Beyond Nurse-Patient Ratios
- How Physicians Can Help Ease Mental Health Provider Shortages
- NPP Demand Rising Under Value-Based Care Models
- Providers Lag as Consumers Set Agenda
- Boston Marathon Bombing Yields Lessons for Hospitals
- Esther Dyson Launches Population Health Challenge
- Physicians as Economic Powerhouses and Tech Laggards
- Hospital Groups Back NQF Report on Patient Sociodemographics